Journal of Parkinson’s Disease 4 (2014) 211–221
Sleep Disorders in PD are common and have negative impact on the patients’ quality of life. The paper published by Schrempf and his colleagues in the Journal of Parkinson’s Disease consider that the concept of REM-Sleep behaviour disorder (RBD) is a good clinical predictor of emerging PD disease compared to other early clinical features. Therefore, an early warning sign for emerging neurodegenerative diseases should be considered in order to find biomarkers to identify patients at risk for developing Parkinson’s disease. Schrempf et al. report that daytime sleepiness as well as sleep attacks can be induced by antiparkinsonian therapy. The authors suggest that management of sleep disorders in PD patients starts with optimization of antiparkinsonian therapy in term of dosage, duration of treatment and timing of application.
Link : http://iospress.metapress.com/content/rxq4n3026057228g/fulltext.pdf
The World Parkinson Coalition is proud to announce a new initiative in September of this year (from Tuesday, September 30 to Thursday, October 2, 2014.)
While this new program will offer six CME/CEU credits for health professionals, it is being designed to be accessible to everyone in the community.
This exciting free webcast will be offered online only and is the first WPC Scientific Update: Parkinson Pipeline Umbrella program they have ever designed. It will take place over three days, with two talks offered each day, from Tuesday, September 30 to Thursday, October 2, 2014.
If you have any questions/need more information, email: email@example.com
Don’t forget the 4th World Parkinson Congress / September 20-23, 2016,
Portland, Oregon, USA
Ride to beat Parkinson’s disease
For further information and / or registration: